Navigation Links
A way to slow the progression of Type 1 Diabetes

According to new research, a new drug that suppresses the immune system may slow the progression of type 1 diabetes. An early-phase clinical trial of 10 people aged 8 to 35 years with type 1 diabetes were treated with anti-CD3 mAb, a modified antibody.// A 14-day course of the drug appeared to slow the progressive decline in insulin production commonly seen in type 1 diabetics.

Patients with type 1 diabetes eventually lose the ability to produce insulin entirely and rely solely on injected insulin to maintain control of their good sugar levels. However, the 12 patients treated with anti-CD3 mAb produced more natural insulin and needed less injected insulin one year after treatment they untreated patients. Researchers believe the drug works on the immune system's destructive T-cells, and effectively suppresses the immune cells involved in the development of diabetes. They believe it also helps to retain insulin production well into the course of the disease.

Kevan Herott, M.D., of Columbia University, felt that, the goal of this trial was to induce tolerance to the beta cell, which is the target of autoimmune destruction in type 1 diabetes. This was in effect achieved, because the clinical effect we saw persisted long after patients had finished treatment with the anti-CD3 antibody.


'"/>




Page: 1

Related medicine news :

1. Hip X-ray can help to find out progression of osteoarthritis
2. Malaria infection can accelerate HIV infection and disease progression
3. Is Diabetes the Leading Cause of Kidney Failure in India
4. Diabetes and Depression often go hand-in-hand
5. Thirty minutes of work up per day reduces the risk of Diabetes
6. Diabetes on the rise
7. Irregular Periods Linked to Diabetes
8. Cinnamon combats Diabetes
9. Good News For Women With Gestational Diabetes
10. Processed Meat, Diabetes connection Found
11. Pancreatic Cancer may be linked to Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... More than ... Democratic Republic of Congo (DRC) thanks to an ambitious venture that conjoined the passions ... as the generous support of the Liberty community. These shoes will save lives from ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... highly specialized asset-light logistics provider of complex transport solutions for mission-critical and ... purchase Unitrans International Corporation, a division of Roadrunner Transportation Systems, Inc. (NYSE: ...
(Date:8/18/2017)... York, NY (PRWEB) , ... August 18, 2017 ... ... launch of this summer’s edition of “Vision & Hearing,” advocating for active, healthy ... campaign focuses on resources available for individuals with hearing impairments and shares the ...
(Date:8/18/2017)... , ... August 18, 2017 , ... ... handling handheld devices. Through an educational webinar, they will present the line of ... chance to learn how easy you can automate everyday pipetting tasks. , Ideal ...
(Date:8/18/2017)... ... August 18, 2017 , ... Hernandez Insurance Agencies, a ... throughout the greater DC region, is inaugurating a “New Leash On Life” charity ... and training them to be companions for veterans in need. , The Semper ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... OCEANSIDE, Calif. , Aug. 15, 2017  AOTI Inc. announced ... Advanced Oxygen Therapy Inc., has recently opened a New York City ... the ever-increasing usage of its unique Topical Wound Oxygen (TWO 2 ... approved by the Accreditation Commission for Health Care (ACHC) under the ... ...
(Date:8/11/2017)... DarioHealth Corp. (NASDAQ: DRIO), a leading global ... solutions, today announced that it will release its second ... a conference call at 9:00am ET. The Company will ... and its strategy and outlook for the remainder of ... Raphael , Chief Executive Officer, and Zvi Ben-David ...
(Date:8/8/2017)... Israel, Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), ... today reports its financial results for the second quarter ... during the second quarter 2017 and to date: ... clinical development programs for the Company,s lead project, BL-8040: ... pivotal study with BL-8040 as novel stem cell mobilization ...
Breaking Medicine Technology: